SNCA and Parkinson disease: Data from genetic studies highlight the role of alpha-synuclein as rare point mutations in SNCA (Eriksen et al., 2003) and genomic multiplications of that locus (Chartier-Harlin et al., 2004) are linked to familial forms of Parkinson's disease in a gene dose-dependent manner.